Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 4 minute read General business news Sagar Cements Q4 and FY25 earnings: Slump in profitability despite operational resilience Sagar Cements reports a ₹7,305 lakh Q4 loss as EBITDA margin shrinks; see how green power, capex plans, and cost controls aim to drive FY26 growth. byPallavi MadhirajuMay 13, 2025